Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome

Rheumatology

Volumn 40, Issue 3, 2001, Pages 290-296

  Legangneux, E ^a,e   Mora, J J ^b   Spreux Varoquaux, O ^c   Thorin, I ^a   Herrou, M ^a   Alvado, G ^b   Gomeni, C ^d  

^a UNIVERSITÉ DE CAEN   (France)

^b Hospital of Bayeux   (France)

^c CENTRE HOSPITALIER DE VERSAILLES   (France)

^d Biotrial   (France)

^e SANOFI   (France)

Author keywords

Cerebrospinal fluid; Dopamine; Matched controls; Norepinephrine; Primary fibromyalgia syndrome; Serotonin

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; ANALGESIC AGENT; BIOGENIC AMINE; DOPAMINE; HOMOVANILLIC ACID; IMIPRAMINE; NORADRENALIN; PARACETAMOL; SALICYLIC ACID DERIVATIVE; SEROTONIN; TRITIUM;

ADULT; AGE; ARTICLE; BINDING AFFINITY; CEREBROSPINAL FLUID; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; CORRELATION FUNCTION; COULOMETRY; DRUG BINDING SITE; DRUG UPTAKE; FEMALE; FIBROMYALGIA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; ISOTOPE LABELING; MALE; MEDICAL SOCIETY; METABOLITE; MODULATION; PAIN; PATHOPHYSIOLOGY; PLASMA; PRIORITY JOURNAL; RECEPTOR DENSITY; REGULATORY MECHANISM; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; RHEUMATOLOGY; SEROTONIN METABOLISM; SEROTONIN UPTAKE; STATISTICAL ANALYSIS; SYNDROME; THROMBOCYTE; TISSUE LEVEL;

EID: 0035057820     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/40.3.290     Document Type: Article

References (33)

1. 'Fibrositis' as a disorder of pain modulation
2. Primary fibromyalgia (fibrositis): Clinical study of 50 patients with matched normal controls
3. Fibrositis: Symptoms, frequency and criteria for diagnosis
4. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the multicenter criteria committee
5. Histological abnormalities in muscle from patients with certain types of fibrositis
6. Muscle biopsy in primary fibromyalgia: Light microscopal and histochemical findings
7. Plasma tryptophan and musculoskeletal pain in non-articular rheumatism ('fibrositis syndrome')
8. Rheumatic pain modulation syndrome: The interrelationships between sleep, central nervous system serotonin and pain
9. Serum amino acids in fibrositis/fibromyalgia syndrome
10. Differential effects of substance P on serotonin-modulated spinal nociceptive reflexes
11. Elevated CSF levels of substance P and high incidence of Raynaud's phenomenon in patients with fibromyalgia: New features for diagnosis
12. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis
13. Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome
14. A world health organization collaborative study: Validity of imipramine platelet binding sites as a biological marker of endogenous depression
15. Initial increase of plasma free serotonin: A biological predictor for the antidepressant response to clomipramine
16. n-Electrode three dimensional liquid chromatography with electrochemical detection for determination of neurotransmitter
17. Reduced Bmax of 3H-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitors
18. Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients
19. Imipramine binding sites on platelets of patients with major depressive disorder
20. Role of the serotonin in the pathophysiology of depression: Focus on the serotonin transporter
21. Fibromyalgia and major affective disorder: A controlled phenomenology and family history study
22. Psychiatric and psychological aspects of fibromyalgia syndrome
23. Is chronic pain a variant of depressive disease? The case of primary fibromyalgia syndrome
24. Biochemical clues to a fibromyalgia-depression link: Imipramine binding in patients with fibromyalgia or depression and in healthy controls
25. 3H-Imipramine binding sites are decreased in platelets of chronic pain patients
26. 5-Hydroxyindol acetic acid in cerebrospinal fluid in fibromyalgia
27. Serotonin levels, pain threshold and fibromyalgia symptoms in the general population
28. Relationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients
29. Serum serotonin concentration in patients with generalized tendomyopathy (fibromyalgia) and rheumatoid arthritis
30. Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18-88 years of age
31. The relationship of mono-amine metabolite in human CSF to age
32. Acid mono-amine metabolites in human CSF and their relationship to age and gender
33. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome